About Index Trending news
Analyze
Top 50 Pricing
TESARO, Inc.

TESARO, Inc.

Work at TESARO, Inc.? Add yourself to this profile

TESARO, Inc.

TESARO is a biopharmaceutical company devoted to providing transformative therapies to people bravely facing cancer.

Elsewhere

Alexa global traffic share

Twitter followers

18 Apr 2016
$50,000,000
Post-IPO equity

SEC FORM D

sec
10 Mar 2016
$155,000,000
Post-IPO equity

SEC FORM D

sec
21 Jun 2011
$101,000,000
Venture capital (Series B)
28 May 2010
$60,000,000
Venture capital (Series A)